Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Seeking FDA Marketing Authorization for Urinary Tract Infection Panel

NEW YORK – OpGen announced on Tuesday that it has submitted a de novo classification request to the US Food and Drug Administration for its Unyvero Urinary Tract Infection (UTI) panel. The submission follows successful completion of its clinical trial of the assay.

The highly multiplexed UTI panel provides quantitative detection of bacterial and fungal pathogens as well as antimicrobial resistance markers directly from urine specimens.

The submission was based on results from a large multicenter study including more than 1,800 patient samples, the Rockville, Maryland-based firm said in a statement.

OpGen said the trial compared the Unyvero UTI panel to various reference tests using different urine sample collection methods. The overall weighted average sensitivity and specificity for the assay was 96.8 percent and 97.4 percent, respectively.

The firm has also tested contrived samples consisting of well-characterized strains at its facility in Germany to provide additional data for low-prevalence strains and antibiotic resistance markers and has generated next-generation sequencing data at its Rockville, Maryland, lab facility to establish genotypic correlation of antibiotic resistance markers detected during the study.

"Following the in-depth analysis of all of our clinical trial data, we have compiled a comprehensive submission package for our de novo classification request, building on a large dataset of Unyvero data and multiple reference methods," said Johannes Bacher, CEO of OpGen, in a statement.

"This marks a major milestone, and we’re looking forward to working closely with the FDA during the interactive review for the Unyvero UTI panel, which we hope [will] become the first high multiplex molecular diagnostic IVD for urine samples granted by the FDA," he added.

The firm expects to present the trial data at the upcoming American Society of Microbiology (ASM) Microbe meeting in June and to publish the data in a peer-reviewed journal. A recent study of its highly multiplexed Unyvero Hospitalized Pneumonia (HPN) panel showed that it reduced the duration of inappropriate antibiotic therapy by an average of 38.6 hours.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.